XLS Medical Max Strength

Nom de l'organisation

InQpharm Consumer Health GmbH

SRN

DE-MF-000008147

Statut du fabricant

Actif

10 avertissements enregistrés — faire défiler le panneau pour tout voir.

• CW135

  EUDAMED n'a pas publié de description pour ce code.
• CW010

  EUDAMED n'a pas publié de description pour ce code.
• CW030

  Please consult your healthcare professional before taking this product » if you are diabetic, as this product may lower plasma glucose levels that consequently reduces insulin secretion. Diabetic patients may have to adjust their daily anti-diabetic treatment to avoid hypoglycaemic attacks. » if any medical conditions exist
• CW999

  Only recommended for adults over 18 years of age. Not recommended for children under 12 years of age. The use of this product by adolescents between 12 to 18 years of age is subject to the supervision of healthcare professionals.
• CW999

  It is recommended to take this product 2 hours apart from any other orally administered medications.
• CW999

  During consumption of this product we recommend you to drink adequate liquid during the day.
• CW999

  Do not take this product » during pregnancy or whilst breastfeeding » if your BMI (Body Mass Index) is below 18.5 » if you are allergic to grape or corn derivatives, or to any of the ingredients listed
• CW999

  Clavitanol™ reduces the digestion of dietary carbohydrates, which may lead to flatulence (passing of gas) in some individuals during the first few days of consumption. This is not a cause for concern, as it will dissipate as soon as your body adapts to the increased amount of undigested carbohydrates.
• CW999

  The incidence of adverse side effects being reported was very rare (< 0.01%). These hypersensitivity reactions were typical of food allergies such as rash, itching, slight swelling, headache, nausea and mild gastrointestinal upset such as stomach pain, bloating, diarrhoea and constipation. In such cases of side effects, treatment should be discontinued.
• CW032

  Do not take after the expiry date

Marché principal en Italie ; disponible dans 7 pays au total.

Dénomination commerciale

XLS Medical Max Strength

Code d'UDI-DI

D-DEMF000008147FCADTB1A4

Basic UDI-DI

B-DEMF000008147FCADTB1A4

Numéro de référence/catalogue

Type B1

Entité d'attribution

EUDAMED

Catégorie de risque

Classe IIb

Législation applicable

MDD [Directive 93/42/CEE relative aux dispositifs médicaux]

Statut

Sur le marché

Quantité

1

Description complémentaire du produit

Eine oral verabreichte Vorrichtung zur Erleichterung der Gewichtsabnahme und zur Behandlung von Fettleibigkeit durch Verringerung der Absorption von mehreren Makronährstoffen (z.B. Fett, Kohlenhydrate und Zucker). Es ist so konzipiert, dass es die Aufnahme der Nährstoffe stört, indem es entweder die Aktivität der Verdauung Enzyme oder durch Bildung eines Komplexes, der zu groß ist, um absorbiert zu werden, und der die Viskosität erhöhen kann und Hydratation des Magen-Darm-Inhalts kann es das Gefühl der Sattheit hervorrufen. Es ist in Tablettenform erhältlich, oder Pulverbeutel in rezeptfreier Form (OTC) zur Verwendung zu Hause oder in der Gesundheitseinrichtung. Dies ist ein einmalgebrauch produkt. Dieses Gerät ist für den Langzeitgebrauch bestimmt. (Aktenzeichen GMDN: 58938)

URL des informations complémentaires

Aucune URL d'informations complémentaires renseignée par le fabricant.

Dimensions cliniques

Aucune dimension clinique enregistrée pour ce dispositif.

• G0402ORALLY ADMINISTERED DEVICES FOR APPETITE CONTROL AND REDUCTION OF INTESTINAL ABSORPTION

• Numéro de lot
• Date d'expiration
• Date de fabrication
• Numéro de série
• Identification du logiciel